Stephenson Harwood LLP has advised UCB Ventures, BGF and 4Bio Capital, who led the funding round. ViaNautis Bio, a pioneer in genetic nanomedicines, has successfully raised...
You must be a Standard 1 Year member to access this content.
Stephenson Harwood advised FPE Capital on portfolio company’s acquisition. NoBlue2, a company within FPE Capital LLP’s portfolio, has announced its acquisition of BrightBridge Solutions Ltd, forming...
You must be a Standard 1 Year member to access this content.
Stephenson Harwood advised BenevolentAI on strategic collaboration with Merck. BenevolentAI has entered into a strategic collaboration with Merck. This collaboration will leverage BenevolentAI’s comprehensive AI platform...
You must be a Standard 1 Year member to access this content.
